vTv Therapeutics (VTVT) Other Working Capital Changes (2014 - 2026)

vTv Therapeutics has disclosed Other Working Capital Changes across 13 years of filings, most recently posting -$105000.0 for Q2 2026.

• In Q2 2026, Other Working Capital Changes rose 72.58% year-over-year to -$105000.0; the TTM figure through Jun 2026 stood at $57000.0 (down 57.14% YoY), while the FY2025 annual figure was -$449000.0, down 307.87% from the prior year.
• Other Working Capital Changes came in at -$105000.0 for Q2 2026 at vTv Therapeutics, up from -$222000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $812000.0 in Q1 2024 to a low of -$16.8 million in Q1 2026.
• Average Other Working Capital Changes over 5 years is -$1.5 million, with a median of -$22000.0 recorded in 2025.
• Year-over-year, Other Working Capital Changes jumped 166.1% in 2022 and sank 170.54% in 2023.
• Over 5 years, Other Working Capital Changes stood at $1.3 million in 2022, then slumped by 170.54% to -$886000.0 in 2023, then jumped by 120.65% to $183000.0 in 2024, then plunged by 153.01% to -$97000.0 in 2025, then decreased by 8.25% to -$105000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$105000.0 in Q2 2026, -$222000.0 in Q1 2026, and -$97000.0 in Q4 2025.